Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
sparsentan | angiotensinogen | small molecule | NA | drugbank | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Focal glomerulosclerosis[MeSHID:D005923] Myocardial Infarction[MeSHID:D009203] |
NA | investigational | unknown |
sparsentan | angiotensin ii receptor type-1 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Focal glomerulosclerosis[MeSHID:D005923] Myocardial Infarction[MeSHID:D009203] |
1.95 | phase 3 | unknown |
sparsentan | angiotensin ii receptor type-1 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Focal glomerulosclerosis[MeSHID:D005923] Myocardial Infarction[MeSHID:D009203] |
1.95 | phase 3 | antagonist |
sparsentan | endothelin a receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Focal glomerulosclerosis[MeSHID:D005923] Myocardial Infarction[MeSHID:D009203] |
5.3 | phase 3 | unknown |
sparsentan | endothelin a receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Focal glomerulosclerosis[MeSHID:D005923] Myocardial Infarction[MeSHID:D009203] |
5.3 | phase 3 | antagonist |
sparsentan | endothelin-1 receptor | small molecule | NA | drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Focal glomerulosclerosis[MeSHID:D005923] Myocardial Infarction[MeSHID:D009203] |
5.3 | investigational | unknown |
sparsentan | endothelin-1 receptor | small molecule | NA | drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Focal glomerulosclerosis[MeSHID:D005923] Myocardial Infarction[MeSHID:D009203] |
5.3 | investigational | antagonist |
click here to return to the previous page |